Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Short-term Investments (2018 - 2025)

Cosmos Health's Short-term Investments history spans 8 years, with the latest figure at $2.7 million for Q4 2025.

  • Quarterly results put Short-term Investments at $2.7 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $2.7 million (changed N/A YoY), and the annual figure for FY2025 was $2.7 million, changed.
  • Short-term Investments for Q4 2025 was $2.7 million at Cosmos Health, up from $33178.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $2.7 million in Q4 2025 to a low of $9987.0 in Q3 2022.
  • The 5-year median for Short-term Investments is $21328.0 (2024), against an average of $193300.2.
  • The sharpest move saw Short-term Investments plummeted 95.27% in 2022, then skyrocketed 85.8% in 2023.
  • Year by year, Short-term Investments stood at $11468.0 in 2021, then grew by 29.76% to $14881.0 in 2022, then surged by 34.9% to $20075.0 in 2023, then rose by 13.61% to $22808.0 in 2024, then skyrocketed by 11931.83% to $2.7 million in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $2.7 million, $33178.0, and $30266.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.